Lv11
90 积分 2023-11-09 加入
China interpretation of vesical imaging-reporting and data system guideline for the management of bladder cancer
2天前
已完结
Intra-osseous basivertebral nerve radiofrequency ablation (BVA) for the treatment of vertebrogenic chronic low back pain
28天前
已完结
Lesion-level heterogeneity of radiologic progression in patients treated with pembrolizumab
29天前
已完结
Dissection of Progressive Disease Patterns for a Modified Classification for Immunotherapy
29天前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
1个月前
已完结
Lutetium-177–PSMA-617 for Prostate Cancer
1个月前
已完结
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
1个月前
已完结
Ulcerative colitis
2个月前
已完结
A Phase II Study of Oportuzumab Monatox: An Immunotoxin Therapy for Patients with Noninvasive Urothelial Carcinoma In Situ Previously Treated with Bacillus Calmette-Guérin
3个月前
已完结
皖公网安备34019202002308
